|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,578 ILa | +24.76% |
|
+14.79% | -36.10% |
| Mar. 31 | Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 10 | Joseph Herman acquired 3.33% stake in Panaxia Labs Israel Ltd for ILS 1 million. | CI |
Panaxia Labs Israel Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was ILS 10.15 million compared to ILS 23.2 million a year ago. Net loss was ILS 4.79 million compared to ILS 17.75 million a year ago.
Basic loss per share from continuing operations was ILS 32 compared to ILS 119 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.10% | 3.76M | |
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +21.03% | 13.41B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B |
PANAXIA LABS ISRAEL LTD 
